High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol

BACKGROUND: Gadofosveset is a gadolinium-based blood pool contrast agent that was approved by the United States Food and Drug Administration in 2008. Its unanticipated withdrawal from production in 2016 created a void in the blood pool agent inventory and highlighted the need for an alternative agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahrouki, Puja, Khan, Sarah N., Yoshida, Takegawa, Iskander, Paul J., Ghahremani, Shahnaz, Finn, J. Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857136/
https://www.ncbi.nlm.nih.gov/pubmed/34936018
http://dx.doi.org/10.1007/s00247-021-05225-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857136/
https://www.ncbi.nlm.nih.gov/pubmed/34936018
http://dx.doi.org/10.1007/s00247-021-05225-2

Ejemplares similares